Bone disease in long-term dialysis

American Journal of Kidney Diseases

Volumn 28, Issue 6, 1996, Pages 918-923

  Golder, Robert ^a   Delmez, James A ^a   Klahr, Saulo ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

hyperparathyroidism; Osteitis fibrosa; osteomalacia; vitamin D

Indexed keywords

PARATHYROID HORMONE;

ADULT; AGED; AMYLOIDOSIS; BONE BIOPSY; BONE DISEASE; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; HYPERPARATHYROIDISM; MALE; OSTEITIS FIBROSA; OSTEOMALACIA; PERITONEAL DIALYSIS;

EID: 0029845322     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(96)90395-9     Document Type: Conference Paper

References (23)

1. Andress DL, Sherrard DJ: The osteodystrophy of chronic renal failure, in Schrier RW, Gottschalk CW (eds): Diseases of the Kidney (ed 5). Boston, MA, Little, Brown, 1993, p 2759
2. Sherrard DJ, Hercz G, Pei Y, Maloney NA, Greenwood C, Manuel A, Saiphoo C, Fenton SS, Segre GV: The spectrum of bone disease in end-stage renal failure: An evolving disorder. Kidney Int 43:436-442, 1993
3. LIach F: Secondary hyperparathyroidism in renal failure: The trade-off hypothesis revisited. Am J Kidney Dis 25:663-679, 1995
4. Malluche H, Faugere M-C: Renal bone disease 1990: An unmet challenge for the nephrologist. Kidney Int 38:193-211, 1990
5. Felsenfeld AJ, Rodriguez M, Dunlay R, LIach F: A comparison of parathyroid-gland function in haemodialysis patients with different forms of renal osteodystrophy. Nephrol Dialysis Transplant 6:244-251, 1991
6. Hercz G, Pei Y, Greenwood C, Manuel A, Saiphoo C, Goodman WG, Segre GV, Fenton S, Sherrard DJ: Aplastic osteodystrophy without aluminum: The role of "suppressed" parathyroid function. Kidney Int 44:860-866, 1993
7. Koch KM: Dialysis-related amyloidosis. Kidney Int 41:1416-1429, 1992
8. Hindi P, Channard J: Destructive spondyloarthropathy in dialysis patients: An overview. Nephron 55:104-109, 1990
9. Allard JC, Artze ME, Porter G, Ghandur-Mnaymned L, De Velasco R, Perez GO: Fatal destructive spondyloarthropathy in two patients on long-term dialysis. Am J Kidney Dis 19:81-85, 1992
10. McMahon LP, Radford J, Dawborn JK: Shoulder ultrasound in dialysis related amyloidosis. Clin Nephrol 35:227-232, 1991
11. Nelson SR, Sharpstone P, Kingswood JC: Does dialysis-associated amyloidosis resolve after transplantation? Nephrol Dialysis Transplant 8:369-370, 1993
12. Tan SY, Pepys MB, Hawkins PN: Treatment of amyloidosis. Am J Kidney Dis 26:267-286, 1995
13. Parfitt AM: Soft tissue calcification in uremia. Arch Intern Med 124:544-556, 1969
14. Wang M, Hercz G, Sherrard DJ, Maloney NA, Sigre GV, Pei Y: Relationships between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. Am J Kidney Dis 26:836-844, 1995
15. Qi W, Monier-Tangere MC, Geng Z, Malluche HH: Predictive value of serum parathyroid levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dis 26:622-631, 1995
16. Andress DL, Maloney NA, Endres DB, Sherrard DJ: Aluminum associated bone disease in chronic renal failure: High prevalence in a long term dialysis population. J Bone Miner Res 1:391-398, 1986
17. Pei Y, Hercz G, Greenwood C, Sherrard DJ, Segre G, Manuel A, Saiphoo C, Fenton S: Non invasive prediction of aluminum bone disease in hemo and peritoneal dialysis patients. Kidney Int 41:1374-1382, 1992
18. 3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic urémie patients. J Clin Invest 92:1436-1443, 1993
19. Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin JK: Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25 dihydroxycholecalciferol in urémie patients. J Clin Invest 74:2136-2143, 1984
20. Rodriguez M, Felsenfeld AJ, Williams C, Pederson JA, Llach F: The effect of long-term calcitriol administration on parathyroid function in hemodialysis patients. J Am Soc Nephrol 2:1014-1020, 1991
21. Sprague SM: Safety and efficacy of long-term treatment of secondary hyperparathyroidism by low-dose intravenous calcitriol. Am J Kidney Dis 19:532-539, 1992
22. Llach F, Hervas J, Cerezo S: The importance of dosing intravenous calcitriol in dialysis patients with severe hyperparathyroidism. Am J Kidney Dis 26:845-851, 1995
23. Bazzi C, Arrigo G, Luciani L, Casazza F, Saviotti M, Malaspina D, Bonucci E, Ballanti P, Amaducci S, Lattuada P, Manna G, Pozzi F, D'Amico G: Clinical features of 24 patients on regular hemodialysis treatment (RDT) for 16-23 years in a single unit. Clin Nephrol 44:96-107, 1995